348572 RESULTS
RESEARCH NEWS 2001-02-06 Research News The enzyme neprilysin-capable of degrading Aβ42 peptide-is a new player in the Alzheimer's disease mystery. Writing in Neuroscience Letters, Patrick McGeer's group at the University of British Columbia adds critical circumstantial
RESEARCH NEWS 2001-02-06 Research News The drugs haloperidol or trazodone, or behavior management techniques (BMT), are commonly used to treat agitation in Alzheimer's patients, but the first large-scale, randomized placebo-controlled study of such treatments has found that
COMMENT I agree that it would be useful to accept a uniform nomenclature. For instance literature searches in Pub med would be more efficient. Sloppiness is probably the most important reason for the current situation and the forum is a good place to discuss the
RESEARCH NEWS 2001-01-26 Research News Glial cells quietly play a much bigger role than ever imagined, according to an article in today's issue of Science. Ben Barres and colleagues at Stanford in California report that astrocytes exert a powerful influence on communication
CONFERENCE COVERAGE 2001-01-19 Conference Coverage ADF/Cofilin Inclusions in Alzheimer's Disease James Bamburg presented a poster (Abstract 2821) on the formation of cellular inclusions composed of actin-depolymerizing factor (ADF) and the cofilin family of proteins (collectively
CONFERENCE COVERAGE SERIES News Summary from the 40th Annual Meeting of The American Society for Cell Biology Part II: News Summary from American Society for Cell Biology Meeting American Society for Cell Biology: 2000 Annual Meeting
RESEARCH NEWS 2001-01-17 Research News The cause of Alexander's disease, a very rare, inherited CNS disorder, has been traced to the gene for glial fibrillary acidic protein (GFAP), according to a report published in this month's Nature Genetics. The disease results in
RESEARCH NEWS 2001-01-11 Research News Three independent studies published in the 22 December issue of Science reported that chromosome 10 probably harbors one or more genes that confer an increased susceptibility to late-onset Alzheimer's disease. The specific gene or genes
CONFERENCE COVERAGE SERIES Symposium: Gene Expression Profiling of Alzheimer's Disease American College of Neuropsychopharmacology 2000 Annual Meeting
CONFERENCE COVERAGE 2001-01-08 Conference Coverage Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico. At this meeting, the speakers discussed the sequence of changes in gene expression in the brain that may take place during the transition from no
RESEARCH NEWS 2000-12-23 Research News The drug selegiline, thought to be neuroprotective, has been used to treat Parkinson's disease for the past 25 years, but a report a few years ago suggested that the drug could accelerate death in patients taking it. A new study from Sc
RESEARCH NEWS 2000-12-22 Research News In today's issue of Science, researchers at the Whitehead Institute and Corning Inc. describe a new microarray technique that can decipher the function of master switches in a cell by identifying the set of genes they control across the
RESEARCH NEWS 2000-12-21 Research News A study presented earlier this week at the 2000 International Chemical Congress of Pacific Basin Societies in Honolulu found that by manipulating the structure of amyloid-β, it was possible to reduce the peptide's ability to induce the
CONFERENCE COVERAGE SERIES Society for Neuroscience Annual Meeting: Stem Cells Drawn to Aβ Society for Neuroscience Annual Meeting: Stem Cells Promising for Motor Neuron Disorders Society for Neuroscience Annual Meeting: Does ApoE Contribute to Tangle Formation? Society for Neurosc
CONFERENCE COVERAGE 2000-12-20 Conference Coverage San Francisco, 9-13 December 2000. Report by Mervyn J. Monteiro, University of Maryland Biotechnology Institute The 40th ASCB meeting began its grand kick-off on Saturday December 9 with an opening symposium by four Nobel Laureates, J.
